Terms: = Breast cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K
5279 results:
1. PI 3-Kinase and the Histone Methyl-Transferase KMT2D Collaborate to Induce Arp2/3-Dependent Migration of Mammary Epithelial Cells.
Rysenkova KD; Gaboriaud J; Fokin AI; Toubiana R; Bense A; Mirdass C; Jin M; Ho MCN; Glading E; Vacher S; Courtois L; Bièche I; Gautreau AM
Cells; 2024 May; 13(10):. PubMed ID: 38786098
[TBL] [Abstract] [Full Text] [Related]
2. The Significance of Thyroid Hormone Receptors in breast cancer: A Hypothesis-Generating Narrative Review.
Quan T; Cockburn J; Dhesy-Thind S; Bane A; Leong H; Geleff C; Devion C; Ajel N; Jerzak KJ
Curr Oncol; 2024 Apr; 31(5):2364-2375. PubMed ID: 38785457
[TBL] [Abstract] [Full Text] [Related]
3. Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification.
Lee M; Yoo TK; Chae BJ; Lee A; Cha YJ; Lee J; Ahn SG; Kang J
Sci Rep; 2024 May; 14(1):11278. PubMed ID: 38760384
[TBL] [Abstract] [Full Text] [Related]
4. CircTRIM1 encodes TRIM1-269aa to promote chemoresistance and metastasis of TNBC via enhancing CaM-dependent MARCKS translocation and pi3k/AKT/mTOR activation.
Li Y; Wang Z; Yang J; Sun Y; He Y; Wang Y; Chen X; Liang Y; Zhang N; Wang X; Zhao W; Hu G; Yang Q
Mol Cancer; 2024 May; 23(1):102. PubMed ID: 38755678
[TBL] [Abstract] [Full Text] [Related]
5. Identification of potential anti-tumor targets and mechanisms of HuaChanSu injection using network pharmacology and cytological experiments in breast cancer.
Yang Z; Wang Y; Huang S; Geng Y; Yang Z; Yang Z
PLoS One; 2024; 19(5):e0303650. PubMed ID: 38753638
[TBL] [Abstract] [Full Text] [Related]
6. Enhancing pathological complete response prediction in breast cancer: the role of dynamic characterization of DCE-MRI and its association with tumor heterogeneity.
Zhang X; Teng X; Zhang J; Lai Q; Cai J
Breast Cancer Res; 2024 May; 26(1):77. PubMed ID: 38745321
[TBL] [Abstract] [Full Text] [Related]
7. Proteogenomic characterization of difficult-to-treat breast cancer with tumor cells enriched through laser microdissection.
Raj-Kumar PK; Lin X; Liu T; Sturtz LA; Gritsenko MA; Petyuk VA; Sagendorf TJ; Deyarmin B; Liu J; Praveen-Kumar A; Wang G; McDermott JE; Shukla AK; Moore RJ; Monroe ME; Webb-Robertson BM; Hooke JA; Fantacone-Campbell L; Mostoller B; Kvecher L; Kane J; Melley J; Somiari S; Soon-Shiong P; Smith RD; Mural RJ; Rodland KD; Shriver CD; Kovatich AJ; Hu H
Breast Cancer Res; 2024 May; 26(1):76. PubMed ID: 38745208
[TBL] [Abstract] [Full Text] [Related]
8. Mechanistic exploration and experimental validation of the Xiaochaihu decoction for the treatment of breast cancer by network pharmacology.
Liu Q; Luo Z; Sun M; Li W; Liu S
Aging (Albany NY); 2024 May; 16(9):7979-7999. PubMed ID: 38742934
[TBL] [Abstract] [Full Text] [Related]
9. The combination of breast cancer PDO and mini-PDX platform for drug screening and individualized treatment.
Cui Y; Ran R; Da Y; Zhang H; Jiang M; Qi X; Zhang W; Niu L; Zhou Y; Zhou C; Tang X; Wang K; Yan Y; Ren Y; Dong D; Zhou Y; Wang H; Gong J; Hu F; Zhao S; Zhang H; Zhang C; Yang J
J Cell Mol Med; 2024 May; 28(9):e18374. PubMed ID: 38722288
[TBL] [Abstract] [Full Text] [Related]
10. The Human Intermediate Prolactin Receptor I-tail Contributes breast Oncogenesis by Targeting Ras/MAPK Pathway.
Shen S; Radhakrishnan SK; Harrell JC; Puchalapalli M; Koblinski J; Clevenger C
Endocrinology; 2024 Apr; 165(6):. PubMed ID: 38713636
[TBL] [Abstract] [Full Text] [Related]
11. pDNA-tachyplesin treatment stimulates the immune system and increases the probability of apoptosis in MC4-L2 tumor cells.
Mahmoudi-Filabadi F; Doosti A
Amino Acids; 2024 May; 56(1):34. PubMed ID: 38691208
[TBL] [Abstract] [Full Text] [Related]
12. Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human breast cancer.
Wescott EC; Sun X; Gonzalez-Ericsson P; Hanna A; Taylor BC; Sanchez V; Bronzini J; Opalenik SR; Sanders ME; Wulfkuhle J; Gallagher RI; Gomez H; Isaacs C; Bharti V; Wilson JT; Ballinger TJ; Santa-Maria CA; Shah PD; Dees EC; Lehmann BD; Abramson VG; Hirst GL; Brown Swigart L; van ˈt Veer LJ; Esserman LJ; Petricoin EF; Pietenpol JA; Balko JM
Cancer Res Commun; 2024 Apr; 4(4):1120-1134. PubMed ID: 38687247
[TBL] [Abstract] [Full Text] [Related]
13. Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors.
Gupta V; Vashisht V; Vashisht A; Mondal AK; Alptekin A; Singh H; Kolhe R
Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674331
[TBL] [Abstract] [Full Text] [Related]
14. Design, Synthesis, Formulation, and Bioevaluation of Trisubstituted Triazines as Highly Selective mTOR Inhibitors for the Treatment of Human breast cancer.
Sun Q; Chu Y; Zhang N; Chen R; Wang L; Wu J; Dong Y; Li H; Wang L; Tang L; Zhan C; Zhang JQ
J Med Chem; 2024 May; 67(9):7330-7358. PubMed ID: 38661655
[TBL] [Abstract] [Full Text] [Related]
15. CircPDE5A-encoded novel regulator of the pi3k/AKT pathway inhibits esophageal squamous cell carcinoma progression by promoting USP14-mediated de-ubiquitination of PIK3IP1.
Lei K; Liang R; Liang J; Lu N; Huang J; Xu K; Tan B; Wang K; Liang Y; Wang W; Lin H; Wang M
J Exp Clin Cancer Res; 2024 Apr; 43(1):124. PubMed ID: 38658954
[TBL] [Abstract] [Full Text] [Related]
16. Elongin B promotes breast cancer progression by ubiquitinating tumor suppressor p14/ARF.
Sui XY; Ma XY; Hou Y; Cao SW; Wang ZQ; Jia LJ; Fan L; Shao ZM; Zhang WJ
Cell Biol Toxicol; 2024 Apr; 40(1):24. PubMed ID: 38653919
[TBL] [Abstract] [Full Text] [Related]
17. Mutant RAS-driven Secretome Causes Skeletal Muscle Defects in breast cancer.
Wang R; Khatpe AS; Kumar B; Mang HE; Batic K; Adebayo AK; Nakshatri H
Cancer Res Commun; 2024 May; 4(5):1282-1295. PubMed ID: 38651826
[TBL] [Abstract] [Full Text] [Related]
18. Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic breast cancer Treated With Abemaciclib: Data From the SCRUM-Japan cancer Genome Screening Project.
Hattori M; Serelli-Lee V; Naito Y; Yamanaka T; Yasojima H; Nakamura R; Fujisawa T; Imai M; Nakamura Y; Bando H; Kawaguchi T; Yoshino T; Iwata H
JCO Precis Oncol; 2024 Apr; 8():e2300647. PubMed ID: 38635933
[TBL] [Abstract] [Full Text] [Related]
19. Photobiomodulation therapy moderates cancer cachexia-associated muscle wasting through activating pi3k/AKT/FoxO3a pathway.
Li Y; Chen Y; Liao Y; Huang T; Tang Q; He C; Xu L; Chang H; Li H; Liu Q; Lai D; Xia Q; Zou Z
Apoptosis; 2024 Jun; 29(5-6):663-680. PubMed ID: 38598070
[TBL] [Abstract] [Full Text] [Related]
20. NTRK3 exhibits a pro-oncogenic function in upper tract urothelial carcinomas.
Lim LM; Lee YC; Lin TW; Hong ZX; Hsu WC; Ke HL; Hwang DY; Chung WY; Li WM; Lin HH; Kuo HT; Huang AM
Kaohsiung J Med Sci; 2024 May; 40(5):445-455. PubMed ID: 38593276
[TBL] [Abstract] [Full Text] [Related]
[Next]
